Standard

Optogenetic Studies of the Pathophysiological Mechanisms and Treatment of Depression. / Dygalo, N. N.; Shishkina, G. T.

In: Neuroscience and Behavioral Physiology, Vol. 49, No. 2, 15.02.2019, p. 178-183.

Research output: Contribution to journal › Review article › peer-review

Harvard

Dygalo, NN & Shishkina, GT 2019, 'Optogenetic Studies of the Pathophysiological Mechanisms and Treatment of Depression', Neuroscience and Behavioral Physiology, vol. 49, no. 2, pp. 178-183. https://doi.org/10.1007/s11055-019-00712-4

APA

Dygalo, N. N., & Shishkina, G. T. (2019). Optogenetic Studies of the Pathophysiological Mechanisms and Treatment of Depression. Neuroscience and Behavioral Physiology, 49(2), 178-183. https://doi.org/10.1007/s11055-019-00712-4

Vancouver

Dygalo NN, Shishkina GT. Optogenetic Studies of the Pathophysiological Mechanisms and Treatment of Depression. Neuroscience and Behavioral Physiology. 2019 Feb 15;49(2):178-183. doi: 10.1007/s11055-019-00712-4

Author

Dygalo, N. N. ; Shishkina, G. T. / Optogenetic Studies of the Pathophysiological Mechanisms and Treatment of Depression. In: Neuroscience and Behavioral Physiology. 2019 ; Vol. 49, No. 2. pp. 178-183.

BibTeX

@article{aba07f6f67234a9c854cfc917c337006,
title = "Optogenetic Studies of the Pathophysiological Mechanisms and Treatment of Depression",
abstract = "Glutamatergic neurotransmission and the active brain neurotransmitter systems support the operation of mechanisms controlling psychoemotional status. Convincing evidence has now been reported on the involvement of brain areas key for regulating emotions, including the prefrontal cortex, hippocampus, nucleus accumbens, ventral tegmental area, serotoninergic raphe nuclei, and amygdala, as well as in the pathogenesis of depression and the therapeutic effects of antidepressants. Impairments to the balance between “excitatory” and “inhibitory” signals to these areas, judging from experimental and clinical data, appear to underlie depressive psychoemotional disorders. Efforts in identifying the mechanisms of depression and antidepressant responses have received significant support because of the development of optogenetic methods and their introduction into research practice. Studies in recent years using optogenetic approaches and the forthcoming translation of their main results into clinical practice are discussed in this review.",
keywords = "depression, optogenetics, parts of the brain, stress",
author = "Dygalo, {N. N.} and Shishkina, {G. T.}",
year = "2019",
month = feb,
day = "15",
doi = "10.1007/s11055-019-00712-4",
language = "English",
volume = "49",
pages = "178--183",
journal = "Neuroscience and Behavioral Physiology",
issn = "0097-0549",
publisher = "Springer New York",
number = "2",

}

RIS

TY - JOUR

T1 - Optogenetic Studies of the Pathophysiological Mechanisms and Treatment of Depression

AU - Dygalo, N. N.

AU - Shishkina, G. T.

PY - 2019/2/15

Y1 - 2019/2/15

N2 - Glutamatergic neurotransmission and the active brain neurotransmitter systems support the operation of mechanisms controlling psychoemotional status. Convincing evidence has now been reported on the involvement of brain areas key for regulating emotions, including the prefrontal cortex, hippocampus, nucleus accumbens, ventral tegmental area, serotoninergic raphe nuclei, and amygdala, as well as in the pathogenesis of depression and the therapeutic effects of antidepressants. Impairments to the balance between “excitatory” and “inhibitory” signals to these areas, judging from experimental and clinical data, appear to underlie depressive psychoemotional disorders. Efforts in identifying the mechanisms of depression and antidepressant responses have received significant support because of the development of optogenetic methods and their introduction into research practice. Studies in recent years using optogenetic approaches and the forthcoming translation of their main results into clinical practice are discussed in this review.

AB - Glutamatergic neurotransmission and the active brain neurotransmitter systems support the operation of mechanisms controlling psychoemotional status. Convincing evidence has now been reported on the involvement of brain areas key for regulating emotions, including the prefrontal cortex, hippocampus, nucleus accumbens, ventral tegmental area, serotoninergic raphe nuclei, and amygdala, as well as in the pathogenesis of depression and the therapeutic effects of antidepressants. Impairments to the balance between “excitatory” and “inhibitory” signals to these areas, judging from experimental and clinical data, appear to underlie depressive psychoemotional disorders. Efforts in identifying the mechanisms of depression and antidepressant responses have received significant support because of the development of optogenetic methods and their introduction into research practice. Studies in recent years using optogenetic approaches and the forthcoming translation of their main results into clinical practice are discussed in this review.

KW - depression

KW - optogenetics

KW - parts of the brain

KW - stress

UR - http://www.scopus.com/inward/record.url?scp=85060959766&partnerID=8YFLogxK

U2 - 10.1007/s11055-019-00712-4

DO - 10.1007/s11055-019-00712-4

M3 - Review article

AN - SCOPUS:85060959766

VL - 49

SP - 178

EP - 183

JO - Neuroscience and Behavioral Physiology

JF - Neuroscience and Behavioral Physiology

SN - 0097-0549

IS - 2

ER -

ID: 18503542